Vázquez-Mahía Inés, Seoane Juan, Varela-Centelles Pablo, Tomás Inmaculada, Álvarez García Augusto, López Cedrún José Luis
Service of Maxillofacial Surgery, A Coruña University Hospital, A Coruña, Spain.
J Oral Maxillofac Surg. 2012 Jul;70(7):1724-32. doi: 10.1016/j.joms.2011.06.228. Epub 2011 Sep 21.
The purpose of this study was to identify significant predictors for oral squamous cell carcinoma recurrence.
This Ambispective cohort study was performed in consecutive metastasis-free patients treated for oral squamous cell carcinoma with curative intent from 1998 through 2003. Variables included gender, age, tumor site, macroscopic pattern of the lesion, coexisting disorders (diabetes, hepatic and heart disorders, other tumors/diseases), degree of differentiation, and pathologic TNM stage. Tumor recurrence was considered the dependent variable (outcome). The distribution of recurrences was assessed with χ(2) test. Survival times were estimated by Kaplan-Meier curves and differences were examined with log-rank test. Multiple Cox regression study was also performed. The significance level chosen for all tests was P < .05.
One hundred eighteen patients entered the study. Tumor recurrence was 44.9% during the follow-up period (10% local, 29.7% regional, and 5% distant). The mean period that had elapsed before recurrence was 15 months (1.5 to 81.8), with most recurrences (66%) during the first year after treatment (84.9% before 2 years). Multivariate Cox regression analysis indicated the presence of a coexisting disorder (P = .022) as the most relevant prognostic factor for relapse, because patients with associated diseases had a 2.43-fold risk of recurrence. Tumor stage (P = .037), degree of differentiation (P = .042), and macroscopic pattern of the lesion (P = .022) were also identified as prognostic factors for relapse.
The risk profile for oral cancer recurrence includes patients younger than 60 years with coexisting diseases whose primary tumor occurred as an ulcerated lesion, and diagnosed at an advanced stage with a poorly differentiated tumor.
本研究旨在确定口腔鳞状细胞癌复发的重要预测因素。
本回顾性队列研究纳入了1998年至2003年期间接受根治性治疗的连续无转移的口腔鳞状细胞癌患者。变量包括性别、年龄、肿瘤部位、病变的宏观形态、并存疾病(糖尿病、肝脏和心脏疾病、其他肿瘤/疾病)、分化程度以及病理TNM分期。肿瘤复发被视为因变量(结果)。采用χ²检验评估复发的分布情况。通过Kaplan-Meier曲线估计生存时间,并使用对数秩检验检查差异。还进行了多因素Cox回归研究。所有检验选择的显著性水平为P <.05。
118例患者进入研究。随访期间肿瘤复发率为44.9%(局部复发10%,区域复发29.7%,远处复发5%)。复发前的平均时间为15个月(1.5至81.8个月),大多数复发(66%)发生在治疗后的第一年(2年内复发率为84.9%)。多因素Cox回归分析表明,并存疾病(P =.022)是最相关的复发预后因素,因为患有相关疾病的患者复发风险是2.43倍。肿瘤分期(P =.037)、分化程度(P =.042)和病变的宏观形态(P =.022)也被确定为复发的预后因素。
口腔癌复发的风险特征包括年龄小于60岁、患有并存疾病、原发肿瘤为溃疡型病变、诊断为晚期且肿瘤分化差的患者。